Rogers, K. A., Thompson, P. A., Allan, J. N., Coleman, M., Sharman, J. P., Cheson, B. D., Jones, D., Izumi, R., Frigault, M. M., Quah, C., Raman, R. K., Patel, P., Wang, M. H. and Kipps, T. J. (2021) “Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia”, Haematologica. Pavia, Italy, 106(9), pp. 2364-2373. doi: 10.3324/haematol.2020.272500.